Johnson & Johnson plans to file for FDA approval of a nasal spray formula called esketamine this year. On Saturday, they presented new research suggesting the drug worked well alongside a traditional antidepressant for a month.

Johnson & Johnson plans to file for FDA approval of a nasal spray formula called esketamine this year. On Saturday, they presented new research suggesting the drug worked well alongside a traditional antidepressant for a month.: https://ift.tt/2IewbtM Read more... https://ift.tt/2IfN3As